Asia Pacific Spirometer Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Handheld Spirometers, Table-top Spirometers, and Desktop Spirometers), Technology (Volume, Flow, and Peak Flow), and Application (Asthma, Chronic Obstructiv

Asia Pacific Spirometer Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Handheld Spirometers, Table-top Spirometers, and Desktop Spirometers), Technology (Volume, Flow, and Peak Flow), and Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, and Others) 

The spirometer market in Asia Pacific is expected to grow from US$ 210.00 million in 2022 to US$ 414.09 million by 2028. It is estimated to grow at a CAGR of 12.0% from 2022 to 2028.
Millions of people across the region are suffering from COPD and asthma, which are the two most common respiratory diseases that can seriously impact people’s health and even cause death. Patients with asthma and COPD should perform daily measurements of static and dynamic respiratory functions to track their pulmonary health and prevent exacerbations easily. Spirometers are the most common machines for such tests. They measure the volume and speed of air inhaled and exhaled to assess lung function and provide a first-level diagnostic test for pulmonary diseases and their progression. In addition, in 2018, the Indian Chest Society and the National College of Chest Physicians of India collaborated to develop evidence-based guidelines to help physicians at all healthcare levels in performing and scientifically interpreting spirometry. They jointly supported an expert group to provide recommendations for spirometry in India. Continuous initiatives by governments are likely to modernize and offer opportunities for the growth of the spirometer market during the forecast period.
Asia Pacific Spirometer Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Spirometer Market Segmentation

The Asia Pacific spirometer market is segmented by type, technology, application, and country. Based on type, the market is segmented into handheld spirometers, table-top spirometers, and desktop spirometers. The table-top spirometers segment dominated the market in 2022. By technology, the market is segmented into volume, flow, and peak flow. The flow segment dominated the market in 2022. By application, the market is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and others. The chronic obstructive pulmonary disease segment dominated the market in 2022. Based on country, the market is segmented into China, Japan, India, South Korea, Australia, and the rest of Asia Pacific. Further, China dominated the market in 2022.
A few key players dominating the Asia Pacific spirometer market are Baxter International Inc.; COSMED Srl; Henry Schein, Inc.; ICU Medical Inc.; Teleflex Incorporated; and VYAIRE MEDICAL, INC.

Reasons to buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific Spirometer Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Spirometer Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Spirometer Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution